CLINICAL_TRIALS
trial_result
· 2021-04-26
Clinical Trial Update: Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS [Phase 3]
Summary
Phase 3 trial evaluating Ryanodex as adjuvant treatment for exertional heat stroke has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eagle Pharmaceuticals, Inc. | Conditions: Exertional Heat Stroke | Phase 3 | Status: COMPLETED | Results posted: 2021-04-26